OPKO Health opts to reduce loan commitments to $100 million

By Marisa Wong

Morgantown, W.Va., May 17 – OPKO Health, Inc.’s wholly owned subsidiary, Bio-Reference Laboratories, Inc., has decided to permanently reduce its aggregate commitment under its credit agreement dated Nov. 5, 2015 to $100 million from $175 million, according to an 8-K filing with the Securities and Exchange Commission.

Bio-Reference gave notice of its election to administrative agent JPMorgan Chase Bank, NA on May 14.

OPKO Health is a Miami, Fla.-based diversified health care company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.